Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of
vasopressin
on choline uptake and phosphatidylcholine biosynthesis in isolated rat heart myocytes was investigated. Myocytes were incubated with labelled choline in the presence of 0.05-1.0 microM
vasopressin
. Uptake of choline was enhanced (25%) by a low concentration (0.2 microM) of
vasopressin
, but was attenuated (19%) by a higher
vasopressin
concentration (1.0 microM). The biosynthesis of phosphatidylcholine was also affected by
vasopressin
in a biphasic manner. At low concentrations of
vasopressin
, a general increase in cytosine triphosphate:
phosphocholine cytidylyltransferase
activity was observed that caused an enhanced conversion of phosphocholine to phosphatidylcholine via the cytidine diphosphocholine pathway. At high
vasopressin
concentrations, a decrease in the activity of cytidylyltransferase was detected, which was caused by the translocation of the enzyme from the microsomal fraction to the cytosolic fraction. The decrease in enzyme activity coincides with a reduction in the conversion of labelled phosphocholine to phosphatidylcholine. In view of the fact that phospholipid biosynthesis in rat hepatocytes is inhibited by
vasopressin
at all concentrations, the biphasic modulation of phosphatidylcholine biosynthesis in rat heart myocytes illustrates the diverse effects of this hormone in different mammalian tissues.
...
PMID:Biphasic modulation of choline uptake and phosphatidylcholine biosynthesis by vasopressin in rat cardiac myocytes. 813 91
Neuropeptide
arginine-vasopressin
((4-8)) (AVP(4-8)) is a metabolite of
arginine-vasopressin
which has been shown to have potent memory-enhancing activity, facilitate neurite elongation and prolongate cell aging. Identification of differentially expressed genes in hippocampus induced by AVP(4-8) is important for understanding the molecular basis of AVP(4-8) function. Differential display PCR and 5'rapid amplification of cDNA Ends were used. One new full length cDNA encoding rat cytidine triphosphate:
phosphocholine cytidylyltransferase
(CCT) beta was thus obtained. Northern blot analysis demonstrated that it was upregulated by AVP(4-8) in mature rat hippocampus. The study of tissue distribution with reverse transcription PCR showed that the gene was abundant in brain. Since CCT catalyzes the formation of cytidine diphosphate choline, which was reported to have a beneficial therapeutic effect on Alzheimer's disease, so we speculated that AVP(4-8) may be a potential candidate for treating Alzheimer's disease by upregulating CCT mRNA level.
...
PMID:Cloning of cytidine triphosphate: phosphocholine cytidylyltransferase mRNA upregulated by a neuropeptide arginine-vasopressin((4-8)) in rat hippocampus. 1073 92